Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 23, 2011


Cepheid said this week that Robert Kwiatkowski has joined the company as vice president of infectious disease research and development.

Kwiatkowski was most recently responsible for managing infectious disease test development in support of multiple automated platforms at Siemens Healthcare Diagnostics. He has also previously held positions at Gentra Systems, acquired by Qiagen in 2006; Third Wave Technologies, Becton Dickinson Molecular Diagnostics, and Digene Diagnostics. Kwiatkowski earned his PhD at John Hopkins University.

InstantLabs this week announced that it has appointed Neil Sharma as director of product development, where he will oversee advancement of the company's assay pipeline for its recently launched Hunter Accelerated PCR system.

Sharma most recently worked for Qiagen, where he specialized in real-time PCR and sequencing-based analysis technologies. He has also held positions with ProteinOne, Genomic Solutions, and Biotage. He holds a PhD from Rice University.

HTG Molecular Diagnostics has appointed Debra Gordon as vice president and chief legal counsel.

Prior to joining HTG, Gordon served as general counsel and head of patent legal for Ventana Medical Systems. She holds a JD from the University of Arizona James E. Rogers College of Law and a PhD from the University of Arizona College of Medicine.

Quest Diagnostics subsidiary OralDNA said recently that it has appointed Ken Clarke as general manager and Michael Dunn as vice president of marketing.

Clarke has previously worked for Clarke Consulting, LabOne, and served as administrative director of the pathology laboratories at Northwestern Memorial Hospital. He holds a BS from Vanderbilt University and master's degrees in healthcare administration and business administration from Washington University.

Dunn has served as sales and marketing director for CDB Corporation; and has also worked at Sirona Dental Systems. He holds a BA in mathematics from the University of North Carolina at Charlotte.

OralDNA markets PCR-based clinical tests for detecting and diagnosing periodontal disease and oral HPV.